Dulera Articles
Price and Preferred Tier main consideration of US physicians in intent to prescribe COPD drugs
12 April 2012
FDA approves Merck' & Co’s Dulera for asthma in patients; firm initiates Ph II trial of Chagas drug candidate
25 June 2010
Showing 1-2 of 2 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
